Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
The collaboration aims to discover new drug targets for gene editing-based therapeutics using GeoMx® Digital Spatial Profiling (DSP) technology and to improve treatment options for patients suffering from interstitial lung diseases, such as idiopathic pulmonary fibrosis.
Lead Product(s): Undisclosed
Therapeutic Area: Pulmonary/Respiratory Diseases Product Name: Undisclosed
Highest Development Status: Discovery PlatformProduct Type: Undisclosed
Partner/Sponsor/Collaborator: Stanford Medicine
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration June 08, 2023